When we launched beatBread in 2020, our intent was to free artists of the onerous economic terms and loss of control that comes with major record deals and provide opportunities […] ...
A growing foray of pharmacy benefit managers’ (PBMs) private labels into the U.S. biosimilar space is intensifying concerns about the antitrust aspects of PBMs’ vertical integration that has them ...